Literature DB >> 22677455

The impact of left ventricular lead position on left ventricular reverse remodelling and improvement in mechanical dyssynchrony in cardiac resynchronization therapy.

H M Kristiansen1, G Vollan, T Hovstad, H Keilegavlen, S Faerestrand.   

Abstract

AIMS: To investigate the influence of left ventricular (LV) lead position on LV dyssynchrony in cardiac resynchronization therapy (CRT). METHODS AND
RESULTS: The LV lead was prospectively targeted to the latest activated LV segment (concordant) evaluated by two-dimensional speckle tracking radial strain (ST-RS) echocardiography in 103 CRT recipients (67 ± 12 years). Mechanical dyssynchrony was assessed by anteroseptal-to-posterior (AS-P) delay and interventricular mechanical delay (IVMD). Concordant LV leads were obtained in 72 (70%) patients. Superior LV reverse remodelling (LV-RR; ≥ 15% LV end-systolic volume reduction at 6-month follow-up) was observed in the concordant LV leads compared with the discordant LV leads [51 (76%) vs. 13 (45%); P = 0.003]. Mechanical resynchronization responders (≥ 50% AS-P delay reduction at 6-month follow-up) obtained in the concordant LV leads [44 (66%)] was greater than in the discordant LV leads [10 (34%); P = 0.005]. The discordant LV leads located adjacent to the concordant LV leads (+1 segment; n = 22) and 2 segments apart (+2 segments; n = 9) were evaluated in a subgroup analysis. Mechanical resynchronization responders 6 months after CRT were as follows: in +1 segment [n = 10 (48%)] and in +2 segments (n = 0; P = 0.001). The concordant LV lead was the only independent predictor of LV-RR at 6-month follow-up (odds ratio, 4.177; P = 0.004). Independent predictors of mechanical resynchronization responders were AS-P delay (odds ratio, 1.007; P = 0.032), IVMD (odds ratio, 1.024; P = 0.038), and concordant LV lead (odds ratio, 4.691; P = 0.004).
CONCLUSION: Concordant LV leads in CRT provided more responders according to both LV reverse remodelling and mechanical resynchronization.

Entities:  

Mesh:

Year:  2012        PMID: 22677455     DOI: 10.1093/ehjci/jes114

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  7 in total

Review 1.  Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.

Authors:  Sokratis Pastromas; Antonis S Manolis
Journal:  World J Cardiol       Date:  2014-12-26

Review 2.  Speckle tracking echocardiography: clinical applications in cardiac resynchronization therapy.

Authors:  Xiaoshan Zhang; Si Ha; Xiaolei Wang; Yilu Shi; Shasha Duan; Zhian Li
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Device therapies: new indications and future directions.

Authors:  Prabhat Kumar; Jennifer D Schwartz
Journal:  Curr Cardiol Rev       Date:  2015

4.  Performance of an active fixation bipolar left ventricular lead vs passive fixation quadripolar leads in cardiac resynchronization therapy, a randomized trial.

Authors:  Havard Keilegavlen; Peter Schuster; Thomas Hovstad; Svein Faerestrand
Journal:  J Arrhythm       Date:  2020-11-08

5.  Echocardiography and cardiac resynchronisation therapy, friends or foes?

Authors:  W M van Everdingen; J C Schipper; J van 't Sant; K Ramdat Misier; M Meine; M J Cramer
Journal:  Neth Heart J       Date:  2016-01       Impact factor: 2.380

6.  Empiric versus imaging guided left ventricular lead placement in cardiac resynchronization therapy (ImagingCRT): study protocol for a randomized controlled trial.

Authors:  Anders Sommer; Mads Brix Kronborg; Steen Hvitfeldt Poulsen; Morten Böttcher; Bjarne Linde Nørgaard; Kirsten Bouchelouche; Peter Thomas Mortensen; Christian Gerdes; Jens Cosedis Nielsen
Journal:  Trials       Date:  2013-04-26       Impact factor: 2.279

7.  High-density epicardial activation mapping to optimize the site for video-thoracoscopic left ventricular lead implant.

Authors:  Rostislav Polasek; Ivo Skalsky; Dan Wichterle; Tomas Martinca; Jana Hanuliakova; Tomas Roubicek; Jan Bahnik; Helena Jansova; Jan Pirk; Josef Kautzner
Journal:  J Cardiovasc Electrophysiol       Date:  2014-05-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.